Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA: a cancer journal for clinicians. 2015;65:5–29.
Google Scholar
Hendrick RE. Radiation doses and cancer risks from breast imaging studies. Radiology. 2010;257:246–53.
PubMed
Google Scholar
Zhou M, Zhong L, Xu W, Sun Y, Zhang Z, Zhao H, Yang L, Sun J. Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients. Sci Rep. 2016;6:31038.
CAS
PubMed
PubMed Central
Google Scholar
Mehta S, Shelling A, Muthukaruppan A, Lasham A, Blenkiron C, Laking G, Print C. Predictive and prognostic molecular markers for cancer medicine. Therapeutic advances in medical oncology. 2010;2:125–48.
CAS
PubMed
PubMed Central
Google Scholar
Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. The oncologist. 2004;9:606–16.
PubMed
Google Scholar
Duffy MJ, O'Donovan N, McDermott E, Crown J. Validated biomarkers: the key to precision treatment in patients with breast cancer. Breast. 2016;29:192–201.
PubMed
Google Scholar
Anothaisintawee T, Wiratkapun C, Lerdsitthichai P, Kasamesup V, Wongwaisayawan S, Srinakarin J, Hirunpat S, Woodtichartpreecha P, Boonlikit S, Teerawattananon Y. Risk factors of breast cancer: a systematic review and meta-analysis. Asia Pac J Public Health. 2013;25:368–87.
PubMed
Google Scholar
Duffy MJ, McDermott EW, Crown J. Use of multiparameter tests for identifying women with early breast cancer who do not need adjuvant chemotherapy. Clin Chem. 2017;63:804–6.
CAS
PubMed
Google Scholar
Györffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123:725–31.
PubMed
Google Scholar
Chanrion M, Negre V, Fontaine H, Salvetat N, Bibeau F, Mac Grogan G, Mauriac L, Katsaros D, Molina F, Theillet C, Darbon JM. A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer. Clin Cancer Res. 2008;14:1744–52.
CAS
PubMed
PubMed Central
Google Scholar
Cronin M, Sangli C, Liu ML, Pho M, Dutta D, Nguyen A, Jeong J, Wu J, Langone KC, Watson D. Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer. Clin Chem. 2007;53:1084–91.
CAS
PubMed
Google Scholar
Knauer M, Mook S, Rutgers EJ, Bender RA, Hauptmann M, van de Vijver MJ, Koornstra RH, Bueno-de-Mesquita JM, Linn SC, van’t Veer LJ. The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat. 2010;120:655–61.
CAS
PubMed
Google Scholar
Ji C, Lin S, Yao D, Li M, Chen W, Zheng S, Zhao Z. Identification of promising prognostic genes for relapsed acute lymphoblastic leukemia. Blood Cells Mol Dis. 2019;77:113–9.
CAS
PubMed
Google Scholar
Wang D-Y, Done SJ, Mc Cready DR, Leong WL. Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populations. Breast Cancer Res. 2014;16:R71.
PubMed
PubMed Central
Google Scholar
Diaz-Romero J, Romeo S, Bovée JV, Hogendoorn PC, Heini PF, Mainil-Varlet P. Hierarchical clustering of flow cytometry data for the study of conventional central chondrosarcoma. J Cell Physiol. 2010;225:601–11.
CAS
PubMed
Google Scholar
Cheadle C, Vawter MP, Freed WJ, Becker KG. Analysis of microarray data using Z score transformation. J Molecular Diagn. 2003;5:73–81.
CAS
Google Scholar
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47-e.
Google Scholar
Wang L, Cao C, Ma Q, Zeng Q, Wang H, Cheng Z, Zhu G, Qi J, Ma H, Nian H. RNA-seq analyses of multiple meristems of soybean: novel and alternative transcripts, evolutionary and functional implications. BMC Plant Biol. 2014;14:169.
PubMed
PubMed Central
Google Scholar
Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci. 1998;95:14863–8.
CAS
PubMed
Google Scholar
Tikole S, Sankararamakrishnan R. A survey of mRNA sequences with a non-AUG start codon in RefSeq database. J Biomol Struct Dyn. 2006;24:33–42.
CAS
PubMed
Google Scholar
Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.
PubMed
Google Scholar
Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2008;37:1–13.
PubMed Central
Google Scholar
Wang P, Wang Y, Hang B, Zou X, Mao J-H. A novel gene expression-based prognostic scoring system to predict survival in gastric cancer. Oncotarget. 2016;7:55343.
PubMed
PubMed Central
Google Scholar
Sorlie T, Tibshirani R, Parker J, Hastie T, Marron J, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100:8418–23.
CAS
PubMed
PubMed Central
Google Scholar
Van De Vijver MJ, He YD, Van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ. A gene-expression signature as a predictor of survival in breast cancer. New England J Med. 2002;347:1999–2009.
Google Scholar
Reis-Filho JS, Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet. 2011;378:1812–23.
CAS
PubMed
Google Scholar
Thompson E, Taube JM, Elwood H, Sharma R, Meeker A, Warzecha HN, Argani P, Cimino-Mathews A, Emens LA. The immune microenvironment of breast ductal carcinoma in situ. Mod Pathol. 2016;29:249.
CAS
PubMed
PubMed Central
Google Scholar
Na-Jin P, Kang D-H. Breast cancer risk and immune responses in healthy women. Oncol Nurs Forum. 2006;33(6):1151–9.
Google Scholar
Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. Int J Cancer. 2010;127:759–67.
CAS
PubMed
Google Scholar
Li Y-Q, Liu F-F, Zhang X-M, Guo X-J, Ren M-J, Fu L. Tumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer. Plos One. 2013;8:e76379.
CAS
PubMed
PubMed Central
Google Scholar
Siu MK, Wong ES, Kong DS, Chan HY, Jiang L, Wong OG, Lam EW, Chan KK, Ngan HY, Le X-F. Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers. Oncogene. 2013;32:3500–9.
CAS
PubMed
Google Scholar
Wang J, Cai X, Xia L, Zhou J, Xin J, Liu M, Shang X, Liu J, Li X, Chen Z. Decreased expression of FOXJ1 is a potential prognostic predictor for progression and poor survival of gastric cancer. Ann Surg Oncol. 2015;22:685–92.
PubMed
Google Scholar
Demircan B, Dyer LM, Gerace M, Lobenhofer EK, Robertson KD, Brown KD. Comparative epigenomics of human and mouse mammary tumors. Genes Chromosomes Cancer. 2009;48:83–97.
CAS
PubMed
PubMed Central
Google Scholar
Worst TS, Reiner V, Gabriel U, Weiß C, Bolenz C. IL1RN and KRT13 Expression in bladder cancer: association with pathologic characteristics and smoking status. Adv Urol. 2014;2014:184602.
PubMed
PubMed Central
Google Scholar
Lee K-M, Park SK, Hamajima N, Tajima K, Choi J-Y, Noh D-Y, Ahn S-H, Yoo K-Y, Hirvonen A, Kang D. Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women. Breast cancer research and treatment. 2006;96:197–202.
CAS
PubMed
Google Scholar
Stahlman MT, Besnard V, Wert SE, Weaver TE, Dingle S, Xu Y, Kv Z, Olson SJ, Whitsett JA. Expression of ABCA3 in developing lung and other tissues. J Histochem Cytochem. 2007;55:71–83.
CAS
PubMed
Google Scholar
Schimanski S, Wild P, Treeck O, Horn F, Sigruener A, Rudolph C, Blaszyk H, Klinkhammer-Schalke M, Ortmann O, Hartmann A. Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. Horm Metab Res. 2010;42:102–9.
CAS
PubMed
Google Scholar
Cuenda A, Lizcano JM, Lozano J. Mitogen activated protein kinases. Frontiers Cell Dev Biol. 2017;5:80.
Google Scholar
Parray AA, Baba RA, Bhat HF, Wani L, Mokhdomi TA, Mushtaq U, Bhat SS, Kirmani D, Kuchay S, Wani MM. MKK6 is upregulated in human esophageal, stomach, and colon cancers. Cancer Invest. 2014;32:416–22.
CAS
PubMed
Google Scholar
Li Z, Li N, Shen L. MAP2K6 is associated with radiation resistance and adverse prognosis for locally advanced nasopharyngeal carcinoma patients. Cancer Manag Res. 2018;10:6905.
CAS
PubMed
PubMed Central
Google Scholar
Wang H-J, Zhou M, Jia L, Sun J, Shi H-B, Liu S-L, Wang Z-Z. Identification of aberrant chromosomal regions in human breast cancer using gene expression data and related gene information. Med Sci Monit. 2015;21:2557.
CAS
PubMed
PubMed Central
Google Scholar
Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria in cancer cells: what is so special about them? Trends Cell Biol. 2008;18:165–73.
CAS
PubMed
Google Scholar
Koc EC, Haciosmanoglu E, Claudio PP, Wolf A, Califano L, Friscia M, Cortese A, Koc H. Impaired mitochondrial protein synthesis in head and neck squamous cell carcinoma. Mitochondrion. 2015;24:113–21.
CAS
PubMed
Google Scholar
Mints M, Mushtaq M, Iurchenko N, Kovalevska L, Stip MC, Budnikova D, Andersson S, Polischuk L, Buchynska L, Kashuba E. Mitochondrial ribosomal protein S18-2 is highly expressed in endometrial cancers along with free E2F1. Oncotarget. 2016;7:22150.
PubMed
PubMed Central
Google Scholar
Labaer J, Wang J, Qiu J, Wallstrom G, Anderson K, Park J, Figueroa J: Plasma autoantibody biomarkers for basal like breast cancer. Google Patents; 2017.
Google Scholar